What is the appropriate evaluation and management for burning dysuria after placement of bilateral urethral stents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Burning Dysuria After Bilateral Ureteral Stent Placement

Burning with urination after bilateral ureteral stent placement is an expected and extremely common complication occurring in approximately 80% of patients, and should be managed with a multimodal pharmacologic approach using alpha-blockers combined with anticholinergics and NSAIDs. 1, 2

Understanding the Problem

Ureteral stent-related symptoms are multifactorial, resulting from:

  • Direct bladder mucosal irritation by the distal stent curl
  • Retrograde reflux of urine through the stent to the renal pelvis
  • Transmission of high bladder pressures during voiding 1, 2

The burning dysuria you're experiencing is part of a constellation of bothersome lower urinary tract symptoms that affect quality of life but are typically self-limited 3.

Immediate Evaluation Required

Rule out infection first - this is critical with bilateral stents:

  • Obtain urinalysis and urine culture immediately - stent-associated UTI occurs in 2-9% of cases and requires treatment, not just symptom management 3
  • Check for fever, flank pain, or systemic symptoms suggesting pyelonephritis or sepsis
  • If infection is present, initiate culture-directed antimicrobial therapy 4

Assess for stent complications:

  • Stent migration (occurs in 5% of cases) 3
  • Obstruction from encrustation (more common with prolonged indwelling time) 5, 6
  • Confirm stent position if symptoms are severe or atypical

Evidence-Based Pharmacologic Management

First-line therapy - Alpha-blockers:

  • These have the strongest evidence for reducing stent-related symptoms 1, 2, 7
  • Mechanism: relax smooth muscle in the bladder trigone and ureter, reducing irritation and reflux
  • Start immediately if not contraindicated

Add anticholinergic medication:

  • Combination therapy with alpha-blockers is more effective than monotherapy 1, 2
  • Addresses urgency, frequency, and bladder irritation
  • Consider patient-specific contraindications (narrow-angle glaucoma, urinary retention risk)

NSAIDs for pain/burning:

  • Should be part of the multimodal approach 2, 7
  • Addresses inflammatory component of mucosal irritation
  • Use judiciously considering renal function and GI risk

Avoid opioids unless severe pain - the burning sensation typically responds better to the above combination 2

Critical Timing Considerations

Stent duration matters:

  • Longer indwelling time (paradoxically) may be associated with less pain after eventual removal 8
  • However, prolonged retention increases risk of encrustation, stone formation, and infection 5, 6
  • Routine stent exchange should occur every 3 months to prevent serious complications 5

For bilateral stents specifically:

  • At least one stent should remain in place to prevent acute kidney injury 4
  • Removal timing should be coordinated with your urologist based on the indication for placement

When Symptoms Require Urgent Re-evaluation

Contact your urologist immediately if you develop:

  • Fever, chills, or flank pain (suggests infection/pyelonephritis)
  • Complete inability to urinate (suggests obstruction)
  • Gross hematuria that doesn't clear
  • Severe pain unresponsive to medications
  • Any signs of sepsis (hypotension, altered mental status)

Common Pitfalls to Avoid

Do not assume all dysuria is "normal stent symptoms" - infection must be excluded, especially with bilateral stents where delayed treatment of obstruction with infection increases mortality risk significantly 4

Do not use antimicrobials prophylactically for asymptomatic patients with indwelling stents - this promotes resistance 9. However, antimicrobial prophylaxis IS indicated at the time of stent exchange procedures 5, 9.

Do not forget the stents - forgotten stents lead to severe complications including massive stone formation, renal dysfunction, and complex surgical interventions 6. Ensure follow-up is scheduled for removal or exchange.

Patient Education Component

You should understand that:

  • These symptoms are expected and occur in 4 out of 5 patients with stents 1
  • Symptoms typically improve with medication but may persist until stent removal
  • The stents are necessary to prevent kidney damage and must remain until your urologist determines it's safe to remove them
  • You need scheduled follow-up - stents cannot be left indefinitely

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.